Among the clinical samples, this correlation was seen in benign hyperplasia, while a very strong positive correlation between the percentage of CD29 (integrin beta1)-positive cells and isoform A expression was observed in the most aggressive cases (stage 3). Here, ITGB1 is linked to neoplasm.